Scholars Central

EditorialPublished 7 Jan 2026

Advancing Drug Development With Pharmacokinetic Modeling

Authors: Dr. Aarav Mehta

Department of Clinical Pharmacology, Horizon College of Health Sciences, Nova Valley University, Orion City, India

Clinical Pharmacology & Biopharmaceutics

Volume 14 · Issue 4 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Pharmacokinetic modeling is fundamental to drug development, guiding dose optimization and predicting interactions. Modern approaches integrate mechanistic insights with population data, utilize PBPK for ADME simulation, and leverage AI/ML for enhanced prediction. PK/PD modeling connects drug exposure to effects, while QSP offers system-level mechanistic understanding. Challenges with sparse data are being addressed, and Bayesian modeling enables adaptive dosing for improved safety and efficacy. These techniques collectively advance drug discovery and clinical application

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Pharmacology & Biopharmaceutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Dr. Aarav Mehta”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels